Ontrack Therapeutics divulges compounds for neurodegenerative diseases
AI Briefing
- • Ontrack Therapeutics Ltd. develops new heterotricyclic compounds for neurodegenerative disease treatment.
- • The compounds have potential therapeutic applications for various neurodegenerative diseases.
- • Company reports promising results for the compounds in preclinical trials.
Source Summary
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Advertisement